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I n t R o d u c t I o n
The transient receptor potential melastatin 2 (TRPM2) 
channel is a nonselective Ca2+-permeable cation chan-
nel with a broad sensitivity to many factors such as Ca2+, 
phosphatidylinositol bisphosphate, and temperature 
(Starkus et al., 2007; Tóth and Csanády, 2012; Song et 
al., 2016; Tan and McNaughton, 2016). Extensive evi-
dence has demonstrated that TRPM2 functions as a 
sensor for oxidative stress (Jiang et al., 2010). Several 
recent studies using transgenic mice have revealed an 
important role for the TRPM2 channel in processes in-
cluding insulin secretion (Uchida et al., 2011; Manna 
et al., 2015), generation of proinflammation cytokines 
(Yamamoto et al., 2008; Di et al., 2012), delayed neuro-
nal death (Alim et al., 2013; Ye et al., 2014), ischemic 
kidney injury (Gao et al., 2014), protection of cardiac 
ischemia-reperfusion damage (Miller et al., 2014), and 
sepsis (Qian et al., 2014). Therefore, it is critical to un-
derstand the mechanism of TRPM2 channel activation 
during oxidative stress.
The homotetrameric TRPM2 channel belongs to the 
TRP channel family. Each TRPM2 subunit contains a 
large intracellular N terminus, the typical six transmem-
brane domains, and a large intracellular C terminus 
(Fig. 1 A). Like TRPM6 and TRPM7, TRPM2 was con-
sidered to be a channel enzyme. The NUDT9 homology 
(NUDT9-H) domain in TRPM2 C terminus is homolo-
gous to the NUDT9 adenosine diphosphate ribose 
(ADPR) hydrolase (∼50% similarity). TRPM2 activation 
by ADPR was originally proposed to be mediated by an 
enzymatic process in which NUDT9-H binds ADPR and 
converts it to AMP and ribose-5-phophate (R5P; Per-
raud et al., 2001, 2003). However, this view was refuted 
by recent work (Tóth et al., 2014; Iordanov et al., 2016), 
which demonstrated that TRPM2 does not possess 
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ADPR hydrolase activity. Nevertheless, binding of ADPR 
to the NUDT9-H domain is essential for the channel 
opening (Perraud et al., 2001; Sano et al., 2001; Csanády 
and Törocsik, 2009; Tóth and Csanády, 2012). An early 
mutagenesis study had proposed that several residues in 
the NUDT9-H domain (e.g., the Nudix motif) may be 
engaged in ADPR binding and/or activation of the 
TRPM2 channel (Perraud et al., 2005), whereas the pre-
cise and whole perspective of ADPR binding remains 
poorly defined.
Computer-aided modeling techniques, in particular 
molecular dynamic (MD) simulations and homology 
modeling, are powerful tools that facilitate the discov-
ery of molecular and structural insights into both 
ligand–receptor interactions and ligand-induced re-
ceptor activation events. These techniques have been 
used in elegant combinations with site-directed muta-
genesis in many previous studies, including identifying 
the key residues for cAMP and cGMP binding and se-
lectivity in the cyclic nucleotide-binding domain of the 
Figure 1. Homology modeling of the nudt9-H domain from the human tRPM2 channel protein. (A) Schematic diagram show‑
ing the membrane topology of the TRPM2 channel proteins. Important domains are labeled in the figure. (B) Sequence alignments 
of the human NUDT9 and NUDT9‑H domain. Red shading with purple border denotes identical residues, and white shading with 
purple border denotes similarities. (C) Ribbon presentation of the homology models of the NUDT9‑H domain based on the human 
NUDT9 structure. The α‑helices, β‑sheets, and loops are labeled in red, cyan, and gray, respectively.
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HCN2 channel (Zhou and Siegelbaum, 2007), showing 
GABA binding sites and conformational changes 
during the activation of the ionotropic GABA receptors 
(Ashby et al., 2012). Similar approaches enabled our 
previous elucidation of the structural mechanisms of 
capsaicin binding and gating of the TRPV1 channel 
(Yang et al., 2015).
Our present study aimed to define molecular interac-
tions between ADPR and the ligand-binding pocket of 
TRPM2. Toward this goal, we generated a structural 
model of the NUDT9-H domain of the TRPM2 channel 
based on the structure of the human NUDT9 protein 
(Shen et al., 2003) and used induced docking and MD 
simulations to identify residues in the NUDT9-H do-
main that coordinate ADPR via van der Waals (VDW) 
forces, electrostatic interactions, and hydrophobic in-
teractions. We provided systematic functional evidence 
from site-directed mutagenesis and patch clamp re-
cording experiments that corroborate their roles in co-
ordinating ADPR. The present study not only identified 
new residues in the NUDT9-H domain of the TRPM2 
channel that are responsible for ADPR binding but 
also yielded a complete picture of ADPR in the 
NUDT9-H domain, which holds the promise to facili-
tate structure-based drug design efforts targeting 
the TRPM2 channel.
M At e R I A l s  A n d  M e t H o d s
cDNA and cell culture
The cDNA encoding the human TRPM2 (hTRPM2) 
channel was provided by A. M. Scharenberg (University 
of Washington, Seattle, WA; Perraud et al., 2001). 
Human embryonic kidney (HEK) 293 cells were used to 
transiently express wild-type (WT) and mutant chan-
nels. Cell culture, transfection, and induced TRPM2 
expression were each described previously (Yang et al., 
2010, 2011; Yu et al., 2014). Mutations were introduced 
by site-directed mutagenesis and confirmed by sequenc-
ing. All chemicals and reagents used were purchased 
from Sigma-Aldrich, except as otherwise indicated.
Electrophysiology
Whole-cell current recordings were performed using an 
Axopatch 200B amplifier (Molecular Devices) at RT, as 
described previously (Yang et al., 2010, 2011; Yu et al., 
2014). For recording ADPR-induced TRPM2 currents, 
the extracellular solution contained 147  mM NaCl, 
2 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM HEP ES, 
and 13 mM glucose, pH 7.4. The intracellular solution 
contained 147 mM NaCl, 0.05 mM EGTA, 1 mM MgCl2, 
10 mM HEP ES, and ADPR at indicated concentrations, 
pH 7.3. For recording calcium-induced TRPM2 cur-
rents, the extracellular solution was the same as that 
used in ADPR activation; the intracellular solution con-
tained 75 mM NaCl, 1 mM MgCl2, 10 mM HEP ES, and 
50  mM CaCl2, pH 7.4. For recording H2O2-induced 
TRPM2 currents, the extracellular and intracellular 
solutions were the same as that used in ADPR activation, 
except that 30% H2O2 was added to the extracellular 
solution with a final concentration of 30 mM. The cell 
membrane potential was held at 0 mV, and a voltage 
ramp of 500-ms duration from −100 mV to 100 mV was 
applied every 5 s. Glass pipettes with a resistance of 3–5 
MΩ were used. Data were acquired at 10 kHz and fil-
tered offline during data analysis. Change of the extra-
cellular solution was performed using an RSC-160 
system (Bio-Logic Science Instruments).
Homology modeling
The amino acid sequence of the NUDT9-H domain of 
the human TRPM2 protein (accession no. O94759; 
TRPM2_HUM AN) was derived from the UniProt data-
base entry, and a similarity search in Protein Data Bank 
(PDB) database was performed by BLA ST. The crystal 
structure of human NUDT9 (NUDT9; PDB accession 
no. 1Q33, chain A) was chosen as the template in build-
ing the model for the NUDT9-H domain. Using Discov-
ery Studio 2.5 software (Accelrys Software Inc.), we 
produced a sequence alignment between the NUDT9 
protein (residues 59–350; PDB accession no. 1Q33) and 
the NUDT9-H domain (UniProt accession no. O94759, 
residues 1236–1503). A total of 10 models were gener-
ated using the Build Homology Models module in Dis-
covery Studio. The final model was chosen by 
considering probability density functions and discrete 
optimized protein energy values and further validated 
using PRO CHE CK and Profile-3D (Laskowski et al., 
1993). Interatomic clashes were removed by 1,500 steps 
of steepest descent minimization, followed by 1,000 
steps of conjugate gradient minimization in a solvated, 
neutralized simulation box with positional restraints ap-
plied to the Cα atoms.
Docking
The induced-fit docking (IFD) protocol in Glide was 
used (Friesner et al., 2004). In IFD, the flexibility of the 
receptor was taken into account by combining a series 
of Glide and Prime processes. In the preliminary Glide 
docking step, the VDW radii scaling factor was set at 0.5 
by default, and a maximum of 80 poses per ligand was 
retained. In the subsequent Prime induced-fit section, 
the residues within a 5-Å vicinity of the ligand were re-
fined, whereas the others were fixed. The receptor–li-
gand complexes were energy minimized to an induced-fit 
conformation. Finally, the best receptor–ligand complex 
was identified using a composite scoring function with 
the Glide XP scoring mode adopted for docking calcu-
lations. The R1433, G1389, and H1488 residues were set 
as the edges of the docking pocket in an 18 × 18 × 18–Å 
cube, and induced docking was subsequently performed 
for ADPR with the NUDT9-H domain of human TRPM2.
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MD simulations
The structure of ADPR complexed with the NUDT9-H 
domain produced by the IFD procedure was explored 
with MD simulations. MD calculations were performed 
using the AMB ER 11 software suite (University of Cali-
fornia, San Francisco, San Francisco, CA). The general 
AMB ER force field (gaff) and the ff99SB force field were 
used for the protein and ligand, respectively. To obtain 
parameters for the small molecules, ab initio quantum 
chemical methods were employed using Gaussian09 
program (Gaussian, Inc.). The geometries were fully op-
timized, and the electrostatic potentials around them 
were determined at HF/6-31G* level of theory. Subse-
quently, the atomic partial charges of the small mole-
cules were obtained by the RESP fitting technique in 
AMB ER 11 (University of California, San Francisco). 
The charges of protein ionizable groups were found to 
be in the standard protonation state at neutral pH. The 
protein–ligand complex was solvated with TIP3P water 
molecules in a periodically repeating truncated octahe-
dral box. The net charge of the system was brought to 
neutrality and physiological ionic strength (0.15 M) by 
addition of dissociated NaCl, keeping an 8-Å distance 
away from any solute atom. The particle mesh Ewald 
algorithm was used to handle the long-range electrostat-
ics in the molecular minimization and MD simulations. 
Before the MD simulations, each system was relaxed 
using a two-stage minimization strategy: the small mole-
cules and water molecules were first subjected to 1,000 
cycles of minimization with the protein backbone con-
strained (50 kcal · mol−1 · Å−2), and the whole system was 
minimized by 2,000 cycles of steepest descent minimiza-
tion without constrain. After minimization, each system 
was gradually heated in the canonical ensemble from 0 
to 300 K over a period of 50 ps, followed by a 20-ns iso-
baric-isothermal MD simulation with a target tempera-
ture of 300 K and a target pressure of 1 atm. The SHA KE 
procedure was used to constrain all bonds involving hy-
drogen atoms. The time step was set to 2 fs. The PME MD 
program in AMB ER 11 was used for the molecular me-
chanics (MM) optimization and MD simulations. A 15-ns 
data production run was performed in the isobaric–iso-
thermal ensemble with positional restraints imposed on 
the last three C-terminal Cα atoms of each subunit (1,000 
kJ · mol−1 · nm−2), to mimic the presence of the trans-
membrane domain. Unless otherwise stated, statistics 
describing ligand motions and intermolecular interac-
tions refer to the mean ± SEM value, as averaged over all 
20 independent binding sites. The coordinates were 
saved every 10 ps during the MD sampling process.
MM/generalized Born surface area (GBSA) binding free 
energy calculations
For all of the calculations below, a total of 50 snapshots 
from 13–15 ns were evenly extracted from the single 
MD trajectory at a time interval of 40 ps. The absolute 
binding free energy (ΔGbinding) was then predicted by 
applying the MM/GBSA approaches according to the 
following equation (Massova and Kollman, 2000):
  Δ  G binding =  G ¯ complex −  ( G ¯ protein +  G ¯ ligand ) = Δ  E MM + Δ  G solv − TΔS, 
where Gcomplex, Gprotein, and Gligand represent the free en-
ergies of the complex, protein, and ligand, respectively. 
ΔEMM is the gas-phase interaction energy calculated 
using the sander program in AMB ER 11, including the 
internal, electrostatic, and VDW energies, and the inter-
nal energy was cancelled based on the single MD trajec-
tory. The solvation free energy ΔEsolv consists of both 
the polar and nonpolar parts, which were denoted as 
ΔGGB and ΔGSA, respectively.
MM/GBSA binding energy decomposition analysis
To illustrate the interactions between each residue and 
ADPR, we performed MM/GBSA decomposition analy-
sis supported by the mm_pbsa module in AMB ER 11. 
The binding interaction of each residue–small-mole-
cule pair consists of four components: the VDW contri-
bution (ΔGvdw), the electrostatic contribution (ΔGele), 
the polar contribution of desolvation (ΔGGB), and the 
nonpolar contribution of desolvation (ΔGSA). ΔGvdw 
and ΔGele were calculated using the sander program in 
AMB ER 11. A total of 50 snapshots extracted from 13 to 
15 ns MD trajectory was used for the calculations of all 
energy components.
Biotinylation assay and Western blot
Biotinylation assays and Western blot were conducted as 
previously described (Lu et al., 2015; Zhang et al., 
2015). In brief, after transfection for 24–36 h, HEK293 
cells were rinsed with ice-cold PBS. The cells were sub-
sequently incubated with a fresh preparation of 0.5 mg/
ml Sulfo-NHS-SS-Biotin (Thermo Fisher Scientific) dis-
solved in PBS with Tween-20 for 30 min. Subsequently, 
unreacted biotin was quenched with PBS containing 
100 mM glycine. The cells were lysed with RIPA buffer 
(10 mM Tris, 150 mM NaCl, 1 mM EDTA, 0.1% SDS, 1% 
Triton X-100, and 1% sodium deoxycholate, pH 7.4) 
and subjected to centrifugation at 12,000 g for 15 min. 
The resulting supernatant was incubated with 40 µl of a 
50% slurry of NeutrAvidin beads (Thermo Fisher Scien-
tific) for 2 h at 4°C with continuous rotation. After sev-
eral washes with RIPA buffer, the biotinylated proteins 
were eluted from the NeutrAvidin beads with 60 µl of 2× 
SDS sample buffer. The primary antibody used was rab-
bit anti–TRPM2 (Ab11168; Abcam), and the secondary 
antibody was goat anti–rabbit IgG-HRP (1:10,000; 
31420; Thermo Fisher Scientific).
Data analysis
Prism 5 software (GraphPad Software) was used for all 
statistical analyses. Electrophysiological recordings from 
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at least five cells were averaged and are presented in the 
text and figures, where appropriate, as means ± SEM. To 
reduce the variation of TRPM2 currents from different 
batches in our data analysis, currents of the mutants 
were normalized with the mean maximal currents of the 
WT TRPM2 recorded on the same day, which were re-
ferred to as the relative currents. The half-maximal ef-
fective concentration (EC50) values were derived from 
fitting the concentration-response relationships to the 
Hill equation (Weiss, 1997).
Online supplemental material
Fig. S1 uses Ramachandran plot analysis to validate the 
reliability of our homology modeling. Fig. S2 indicates 
that the predicted residues are highly conserved in the 
TRPM2 proteins of various species. Fig. S3 showed the 
merged figure of the model similar to the one previ-
ously proposed and our prediction.
R e s u lt s
Homology modeling of the NUDT9-H domain and 
molecular docking of ADPR
The NUDT9-H domain of the TRPM2 channel 
(S1237-Y1503) is a close homologue of the human 
NUDT9 protein for which the apo structure was deter-
mined at 1.8 Å resolution (PDB accession no. 1Q33; 
Shen et al., 2003). Amino acid sequence alignment 
analysis showed that the NUDT9 and NUDT9-H do-
mains have 52% similarity and 35% identity (Fig. 1 B), 
which is above the generally accepted threshold of 30% 
of sequence identity for modeling reliability (Ashby et 
al., 2012). The location of α-helixes, β-sheets, and loops 
in both proteins are well conserved (Fig. 1 C). The reli-
ability of our homology modeling was validated by Ram-
achandran plot analysis (Fig. S1). Further refinement 
of the structural model by energy minimization resulted 
in 99.6% of the residues falling within the favored/al-
lowed region of the Ramachandran plot. The tertiary 
structural model of the NUDT9-H domain is very simi-
lar to that of NUDT9 (Fig. 2 A).
To investigate the configuration of the bound ADPR 
and its interaction with the ligand-binding domain, 
ADPR (for which the chemical structure is shown in 
Fig.  2  B) was docked into the structural model. The 
results predicted that ADPR takes a saddle-like confor-
mation inside the NUDT9-H domain. A subset of 11 
residues were identified to interact with ADPR. Specif-
ically, the terminal ribose ring in ADPR makes direct 
contacts with L1379, G1389, and E1409; the pyrophos-
phate group interacts with H1346, T1347, S1391, and 
R1433; and the adenosine base interacts T1349, 
D1431, L1484, and H1488 (Fig.  2, B and C). Five of 
these residues—T1349, L1379, S1391, R1433, and 
H1488—have been previously proposed to participate 
in ADPR binding, which was based on the observed 
interactions between the corresponding residues in 
the NUDT9 protein and R5P in the crystal complex 
(Shen et al., 2003).
Validating the stability of modeled ADPR/NUDT9-H 
complex with MD simulations
MD simulations were performed for the ADPR-bound 
state of the NUDT9-H domain. We performed 15-ns 
simulations of the ADPR/NUDT9-H complex. The root 
mean square deviations of protein backbone atoms for 
the complex reached equilibrium after 9 ns at ∼5 Å 
(Fig. 2 D). The bound ligands remained in their origi-
nal conformation during the 15-ns MD simulations. No 
large alterations in the secondary structures were de-
tected during the simulations, further demonstrating 
the stability of this ligand-binding pocket. Furthermore, 
our simulations provide insight into the local, short-
range interactions that occur between ADPR and partic-
ular residues in the NUDT9-H domain. Based on the 
frames from the 15-ns MD simulation trajectory, the 
component energies of ADPR binding to the NUDT9-H 
domain were calculated, including the ELE (electro-
static energy), VDW (VDW energy), INT (bond, angle, 
and dihedral energies), mean electrostatic (Coulom-
bic) and VDW potential energies of interaction GBS UR 
(hydrophobic contribution to solvent free energy for 
generalized Born calculations), as well as the GB (reac-
tion field energy calculated by GB; Table 1). Moreover, 
the interactions between ADPR and each of the 11 resi-
dues identified in the molecular docking were assigned 
into VDW force, electrostatic interaction, polar solva-
tion, and nonpolar solvation groupings, and their con-
tributions to the binding energy for ADPR were 
calculated (Table 2). This analysis provided an index of 
the relative contributions of different residues to the 
strength of ligand binding. MM/GBSA binding free en-
ergy calculations supported that the 11 residues make 
strong interactions with ADPR, which were subject to 
further mutagenesis study.
Alanine scanning validated our predicted binding 
clefts for ADPR
To obtain experimental evidence to verify the predicted 
binding pockets of ADPR, we initially performed ala-
nine scanning of the 11 critical residues identified by 
the molecular docking and MD simulations. Whole-cell 
recordings were performed to measure ADPR-induced 
currents in HEK293 cells expressing hTRPM2 WT or 
mutant channels. A representative current recording of 
the WT channel activated by ADPR is shown in the left 
panel of Fig. 3 A, with the voltage-dependent current 
measured with the ramp protocol shown in the right 
panel. The I-V relationship exhibits linearity and strong 
sensitivity to inhibition by acidic pH, as reported previ-
ously (Yang et al., 2010). Previous studies using whole-
cell recording have determined the EC50 value of ADPR 
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from the concentration-response relationship to be 10 
to 90 µM (Perraud et al., 2001; Starkus et al., 2007). Our 
measurements yielded an estimate of the EC50 value of 
40 µM; the consistency with previous studies further val-
idated our system. Two concentrations, at approxi-
mately EC10 (3 µM) and EC90 (100 µM) of ADPR, were 
used to activate the mutant forms of TRPM2. None of 
the mutants, with the exception of S1391A and L1379A, 
were completely activated by ADPR (Fig. 3 C), support-
ing the idea that these residues are critical for ADPR 
binding. To examine whether the observed loss of func-
tion in mutants was because of defective membrane 
trafficking, a biotinylation assay was used to determine 
surface expression of the mutant proteins. All of the 
nonfunctional mutants were delivered to the cell sur-
face, as with the WT hTRPM2 channel (Fig. 3 D).
Given that most of these 11 residues have not been 
investigated previously, we next addressed their roles in 
ADPR-induced activation of the hTRPM2 channel by 
characterizing the effects of point mutations on chan-
nel function. To avoid current variation resulting from 
variable expression level of WT or mutants in different 
batches of cells, we controlled the experimental condi-
tion as follows: (a) strictly 50 ng EGFP and 1 µg WT or 
Figure 2. docking of AdPR to the nudt9-H domain of tRPM2. (A) The tertiary structure of human NUDT9 (gray) and the model 
of NUDT9‑H domain. (B) Chemical structures of ADPR. The terminal ribose is circled with orange; the pyrophosphate is boxed with 
green; and the adenosine is circled with blue. (C) Ribbon presentation of the binding pocket in the NUDT9‑H domain (gray) docked 
with ADPR. The key residues mediating binding of ADPR are highlighted. (D) MD simulation of the NUDT9‑H domain in complex 
with ADPR: the root mean square deviation (RMSD) of ADPR (red) and ADPR‑binding protein (black), respectively.
Table 1. Binding energy of AdPR with nudt9-H
energy Mean sd
kcal/mol kcal/mol
ELE (electrostatic energy) −44.42 7.33
VDW (VDW energy) −45.09 4.10
INT (bond, angle, dihedral 
energies)
0.00 0.00
GAS (ELE + VDW + INT) −89.51 7.13
GBS UR (hydrophobic contributor 
to solvent free energy for GB 
calculations)
−6.04 0.37
GB (reaction field energy 
calculated by GB)
71.03 4.94
GBS OL (GBS UR + GB) 65.00 4.81
GBE LE (GB + ELE) 26.61 4.67
GBT OT (GBS OL + GAS) −24.52 3.51
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mutant hTRPM2 plasmids were mixed and used for 
transfecting HEK293 cells; (b) electrophysiology exper-
iments were performed 24–36 h after transfection; and 
(c) cells with similar green fluorescence intensity and 
cell size were chosen for patch-clamp recording. In ad-
dition, considering that some of the mutants failed to 
yield a saturated response even at millimolar concentra-
tions of ADPR, all currents from the mutant channels 
were normalized to the maximal currents of WT 
hTRPM2 recorded on the same day and referred to as 
the relative currents.
Residues interacting with the terminal ribose of ADPR
ADPR is composed of three moieties: a terminal ribose, 
a pyrophosphate, and an adenosine (Fig. 2 B). Our re-
sults so far predicted that each of these moieties inter-
acts with a different subset of residues in the NUDT9-H 
domain. Therefore, each of the residues was individu-
ally mutated to selected amino acids depending on the 
nature of the predicted interactions they form with 
ADPR. The mutational effects on ADPR-induced 
TRPM2 channel activation were evaluated.
L1379, G1389, and E1409 were predicted to interact 
with the terminal ribose of ADPR (Fig. 4 A). Sequence 
alignments indicate that these residues are highly con-
served in the TRPM2 proteins of various species (Fig. 
S2). E1409 was predicted in our MD simulation to have 
a strong polar solvation interaction between its hy-
droxyl oxygen atom and the terminal ribose of ADPR 
(Table  2). In support of this prediction, the E1409A 
mutation caused a dramatic increase in the EC50 value 
for ADPR (Fig. 4 B and Table 3). Furthermore, we pro-
duced the E1409Q mutant that would disrupt electro-
static interaction but maintain polar hydrogen bonding 
with the ligand. In contrast to E1409A, the E1409Q 
mutation caused a strong increase in sensitivity to 
ADPR (Fig.  4  B and Table  3), supporting the impor-
tance of the polar solvation interaction between this 
residue and the terminal ribose of ADPR.
L1379 was predicted to interact with the terminal ri-
bose via VDW forces (Table 2). The L1379A mutation, 
which shortened the side chain of leucine, had no sig-
nificant effect on the sensitivity to ADPR (Table 3), sug-
gesting that VDW force might not be critical for L1379. 
However, introducing a polar group by a L1379S muta-
tion not only increased the sensitivity to ADPR, but also 
resulted in a much shallower slope of the concentra-
tion-response curve (Fig. 4 C and Table 3). These strong 
effects, although not necessarily supporting the exis-
tence of specific VDW interactions, suggest the predic-
tion that L1379 directly participates in mediating 
ligand–host interaction.
Our simulation suggested the occurrence of an 
electrostatic interaction between the carboxyl group 
of G1389 and the hydroxyl group of the terminal ri-
bose ring of ADPR. To examine this prediction, G1389 
was mutated to alanine to add a methyl group to gly-
cine, which has the smallest side chain among all 
amino acids. Our result showed that the G1389A mu-
tant failed to be activated by ADPR (Fig.  3  C). This 
result, although consistent with our prediction that 
G1389 is critical for ADPR binding, prevented us from 
constructing the concentration-response relationship 
as we did for mutants of E1409 and L1379. To further 
exclude the possibility that G1389A mutation affected 
the channel gating function, we tested with whole-cell 
patch recording whether this mutant could be acti-
vated by calcium or H2O2, which were previously re-
ported to independently activate TRPM2. Consistent 
with our biotinylation data, G1389A mutant was found 
to be readily activated by calcium, confirming that 
this mutant retained channel function (Fig. 4, D and 
E). Interestingly, our data further showed that H2O2 
failed to induce a current from G1389A mutant 
(Fig. 3, F and G), which suggests that H2O2 may regu-
late TRPM2 channel through the NUDT9-H domain. 
In summary, the collective results indicate that the 
terminal ribose of ADPR likely makes direct contacts 
with L1379, G1389, and E1409 in the NUDT9-H do-
main of TRPM2. Differences in the properties of these 
individual residues lead to their diverse contributions 
to ligand binding.
Table 2. Binding energy values of residues interacting with AdPR in the nudt9-H domain
Residues VdW electrostatic Polar solvation nonpolar solvation total
kcal/mol kcal/mol kcal/mol kcal/mol kcal/mol
HIS1346 −1.40 −1.60 2.10 −0.23 −1.13
THR1347 −0.55 −6.53 0.23 −0.06 −6.91
TYR1349 −1.85 −2.99 2.94 −0.11 −2.01
LEU1379 −1.04 0.11 −0.49 −0.17 −1.60
GLY1389 −0.99 −3.22 1.01 −0.20 −3.40
SER1391 −0.14 0.27 −0.03 −7.32E-05 0.10
GLU1409 −0.09 1.08 −0.73 −0.01 0.26
ASP1431 −0.67 −3.14 3.98 −0.13 0.04
ARG1433 −1.17 0.30 0.72 −0.30 −0.45
LEU1484 −0.04 −0.10 −0.05 0.00 −0.18
HIS1488 −2.07 −1.16 0.93 −0.20 −2.51
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Residues interacting with the pyrophosphate of ADPR
A previous study showed that the pyrophosphate group 
of ADPR is critical for ADPR binding to the NUDT9-H 
domain (Moreau et al., 2013). However, channel resi-
dues in the ligand-binding domain that interact with 
the pyrophosphate have not been identified. Our simu-
lations identified H1346, T1347, S1391, and R1433 as 
the candidate residues that interact with the pyrophos-
phate group (Fig. 5 A). Of note, these residues are also 
widely conserved (Fig. S2). Among these four residues, 
MD simulations suggested the imidazole ring of H1346 
makes electrostatic interactions with the pyrophosphate 
group (Table 2). Functional tests showed that structural 
perturbations by either H1346A or H1346F mutation 
left the mutant channels completely insensitive to ADPR 
(Fig. 5 B), consistent with the idea that the electrostatic 
interactions mediated by H1346 might be critical for 
ADPR binding. In further support of this view, the 
Figure 3. Alanine substitution scanning of 11 identified residues in AdPR-binding pockets. (A) 100 µM ADPR‑induced TRPM2 
currents traces at −80 mV (left panel) and the I‑V relationship curves (right panel, at time points indicated by a1 pointed to before pH 
5.0 treatment and b1 pointed to after pH 5.0 inhibiting TRPM2 channel). W.C., whole cell. (B) The concentration–current response 
relationship for ADPR and the WT TRPM2 channel. Data are expressed as mean ± SEM from seven independent repetitions. (C) 
Summary of the currents induced by EC10 (gray) and EC90 (black) concentrations of ADPR. Data are expressed as mean ± SEM from 
at least five independent repetitions. (D) Biotinylation assay for surface expression of the TRPM2 and its mutants. The eight mutants 
that exhibited no channel function were expressed on the cell surface in HEK293 cells. The top panel shows surface expression, and 
the bottom panel shows total expression. Arrows indicate the specific band size of WT and the indicated TRPM2 mutants.
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Figure 4. characterization of interactions between the terminal ribose of AdPR and the nudt9-H domain. (A) Ribbon presen‑
tation of the terminal ribose binding pockets in the NUDT9‑H domain (gray). The interactions are denoted with yellow dashed lines. 
(B and C) Characterization of the ADPR concentration–current response relationship for the WT (dashed line) and indicated mutants 
(continuous line) of the TRPM2 channels. Data are expressed as mean ± SEM from five independent repetitions. (D) The represen‑
tative traces induced by 50 mM calcium in HEK293 blank cell, TRPM2, and G1389A mutant–transfected cells. (E) Summary of the 
currents in D. (F) The representative trace induced by 10 mM H2O2 in HEK293 blank cell, TRPM2, and G1389A mutant–transfected 
cells. (G) Summary of the currents in F). Data in E and G are expressed as mean ± SEM from at least six independent repetitions.
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H1346W mutation reduced the sensitivity to ADPR 
(Fig. 5 B), highlighting the importance of electrostatic 
interaction with ADPR binding as the replacement with 
a benzene ring by the mutation is expected to obviate 
the electronic property of histidine.
Our simulations predicted that T1347, located in 
close vicinity to H1346, is also important in the electro-
static interaction with ADPR (Table 2). To validate this 
prediction, we generated T1347A, T1347I, T1347F, and 
T1347Y mutants. T1347I mutant channels completely 
lost sensitivity to ADPR, whereas T1347A mutant chan-
nels yielded only a minor response to ADPR (Fig. 5 C), 
consistent with the expectation that eliminating the po-
tential electrostatic interaction would substantially af-
fect ligand–channel interaction. Moreover, the T1347F 
and T1347Y mutants slightly reduced sensitivity to 
ADPR (Fig. 5 C), which could be interpreted that the 
addition of a benzene ring at this position introduced 
steric hindrance that may interfere with the electro-
static interaction between the hydroxyl group of T1347 
and ADPR. It is noted that the slopes of the ADPR con-
centration-response curves for both the T1347F and 
T1347Y mutants were substantially altered, indicating a 
likely change of the binding pattern (Fig. 5 C). These 
results together supported the notion of a critical role 
of the side chain of threonine in ADPR binding to the 
NUDT9-H domain.
VDW force interactions were predicted to occur be-
tween S1391 and the pyrophosphate group of ADPR 
(Table  2). Interestingly, the S1391A mutant that in-
creased the distance between the residue and ADPR 
had a dramatically decreased EC50 for ADPR (Fig. 5 D 
and Table 3). Furthermore, neither the S1391F muta-
tion, which replaced the polar hydroxyl group with a 
nonpolar benzene ring, nor the S1391Y mutation, 
which increased the length of the side chain in serine, 
had noticeably altered the channel sensitivity to ADPR 
(Fig. 5 D), suggesting that the hydroxyl group of this 
residue was not critical for ADPR binding. These obser-
vations are consistent with the prediction that VDW 
force might have a major contribution to ADPR bind-
ing at this site.
Additionally, the VDW force and a minor nonpolar 
solvation interaction between R1433 and the pyrophos-
phate of ADPR were predicted in our simulations 
(Table 2). This prediction appeared rather strange in 
that the charged residue arginine unexpectedly pro-
vides no contribution to electrostatic or polar solvation 
interactions. To further investigate this prediction, we 
produced a series of mutations to change the length, 
polarity, and charge characteristics of the side chain at 
this position. Among R1433A, R1433K, R1433L, 
R1433Q, and R1433G mutants, only the R1433G mu-
tant exhibited a low affinity for ADPR, whereas all of the 
others had no response to ADPR (Fig. 5 E and Table 3). 
Although these results did not validate the accuracy of 
the prediction in our simulations, they are consistent 
with the importance of this residue for ADPR binding 
to the NUDT9-H domain.
Residues interacting with the adenosine region of ADPR
Our simulations predicted that Y1349, D1431, L1484, 
and H1488 contribute in the interaction with the ade-
nosine group of ADPR (Fig. 6 A). For Y1349, it interacts 
with the adenine of ADPR through a π–π interaction, 
which is a form of electrostatic interaction. In addition, 
an interaction between its hydroxyl group and the ter-
minal ribose was predicted (Fig. 6 A and Table 2). Our 
mutagenesis experiments showed that the Y1349F mu-
tation did not significantly alter channel activation by 
ADPR (Fig. 6 B), indicating that the hydroxyl group of 
Y1349 contributed little to ADPR binding. However, 
neither Y1349A nor Y1349S mutant could be activated 
by ADPR (Fig. 6 B). Even the Y1349I mutant, which has 
the longest side chain, exhibited a very low response to 
ADPR. These observations suggest that the benzene 
ring of Y1349 is critical for ADPR binding. Our data are 
consistent with the idea that a π–π interaction mediated 
by the benzene ring of Y1349 is required for ADPR 
binding (Fig. 6 B).
Our simulations also predicted a strong electrostatic 
interaction between D1431 and ADPR (Table  2). Re-
sults from mutagenesis experiments supported this 
prediction, as the D1431A mutation exhibited almost 
no response to ADPR, whereas the D1431N mutant, 
which neutralized the negative charge of aspartic acid, 
Table 3. the ec50 values of AdPR for the mutants in the 
nudt9-H domain of tRPM2
Mutants ec50 ± seM Hill slope
µM
WT 40.5 ± 4.5 2.6
H1346A NF NA
H1346W 112.5 ± 6.4 2.0
T1347A NF NA
T1347F 92.9 ± 11.2 1.2
T1347Y 115.1 ± 13.4 1.3
Y1349A NF NA
Y1349I >10 mM NA
L1379A ND NA
L1379S 10.8 ± 3.5 1.0
S1391A 3.5 ± 0.2 2.7
E1409A 506.3 ± 108.7 1.5
E1409Q 5.4 ± 1.6 1.6
D1431A NF NA
D1431N >100 mM NA
R1433A NF NA
R1433K NF NA
R1433G >10 mM NA
L1484V ND NA
H1488A NF NA
H1488F >10 mM NA
NA, not applicable; ND, EC50 value is not significantly different from the 
WT, based on the measurements of currents induced by EC10 and EC90 
concentrations of ADPR; NF, EC50 value is not defined because the mutation 
fails to yield a saturated response even at millimolar concentrations of ADPR.
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had a much higher EC50 value for ADPR than that of 
the WT channel (Fig. 6 C and Table 3). These results 
support the notion that the likely electrostatic interac-
tion from D1431 is necessary for ADPR binding to the 
NUDT9-H domain.
In addition, our MD simulations suggested a weak 
VDW force between the isobutyl side chain of L1484 
and the adenosine (Table  2). The lack of channel 
function in the L1484A mutant, which has a decreased 
distance between the side chain of this residue and 
ADPR, supports the notion of an important role in 
ADPR binding for the VDW force interaction 
(Fig.  3  C). In further support of this notion, when 
L1484 was mutated to valine that has a similar isopro-
pyl side chain, the binding affinity of ADPR did not 
change (Table 3).
H1488 was predicted to interact with the adenosine 
of ADPR by both VDW force and electrostatic interac-
tions (Table 2). Our mutagenesis experiments showed 
that the H1488F mutant that lost the positive charge on 
the imidazole ring of histidine had a much-reduced 
sensitivity to ADPR (Fig. 6 D), consistent with that dis-
Figure 5. characterization of interactions between the pyrophosphate of AdPR and the nudt9-H domain. (A) Ribbon pre‑
sentation of the pyrophosphate binding pockets in the NUDT9‑H domain (gray). The interactions are denoted with yellow dashed 
lines. (B–E) Characterization of the ADPR concentration–current response relationship for the WT (dashed line) and the indicated 
mutant (continuous line) of the TRPM2 channels. The insets in B–E represent summary of the currents from additional mutants of the 
indicated residues when activated by 100 µM (black) or 3 µM (gray) ADPR. Data in B–E are expressed as mean ± SEM from at least 
five independent repetitions.
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ruption of electrostatic interaction did affect the bind-
ing affinity between H1488 and ADPR.
A working model of ADPR binding inside 
the NUDT9-H domain
Collectively, our mutagenesis and functional assay re-
sults not only demonstrated that most of the residues 
predicted in our MD simulations are indeed critical for 
ADPR binding, but also lent support to the idea of an 
interaction force between ADPR and H1346, T1347, 
Y1349, S1391, E1409, D1431, L1484, and H1488. A 
working model for ADPR binding to the NUDT9-H do-
main of TRPM2 that incorporates our observations is 
presented in Fig. 7. The identified key residues (shown 
in Fig. 7 C in green) define a clear outline of the bind-
ing pocket for ADPR. In this model, the molecular sur-
face of the binding pocket contains two large cavities: 
one accommodates the adenine by the space parallel to 
the purine ring of ADPR, which is mainly formed by 
L1484 and H1488; the other one is formed by L1379, 
G1389, and E1409 to enwrap the terminal ribose of 
ADPR. Between these two moieties, the other critical 
residues of the NUDT9-H domain formed a shallower 
trench, with the pyrophosphate and the ribose of the 
adenosine of ADPR lying in it.
d I s c u s s I o n
In this study, we investigated binding of ADPR to the 
NUDT9-H domain and proposed a detailed structural 
model for atomic interactions that mediate ligand–
host interactions. This model is not only supported by 
our systematic functional tests but also by results from 
previous studies. Indeed, recent studies have identi-
fied several residues clustered in regions of the 
NUDT9-H domain that are critical for ADPR-induced 
activation of the TRPM2 channel (Perraud et al., 2005; 
Du et al., 2009; Tóth et al., 2014). Although these indi-
vidual sites alone could not reveal the precise and 
complete binding mode of ADPR within the NUDT9-H 
domain, when mapped on our model, it becomes clear 
how they may contribute to ligand binding. Based on 
the crystal structure of human NUDT9 and the Esche-
richia coli ADPRase–ADPR complex, Shen et al. 
(2003) initially proposed a hypothetical model of 
ADPR binding to the NUDT9-H domain. A subsequent 
Figure 6. characterization of interactions between the adenosine of AdPR and the nudt9-H domain. (A) Ribbon presentation 
of the adenosine binding pockets in the NUDT9‑H domain (gray). The interactions are denoted with yellow dashed lines. (B–D) Char‑
acterization of the ADPR concentration–current response relationship for the WT (dashed line) and the indicated mutant (continuous 
line) of the TRPM2 channels. The inset in B represents a summary of the currents from additional mutants of the indicated residue 
when activated by 100 µM (black) or 3 µM (gray) ADPR. Data in B–D are expressed as mean ± SEM from five independent repetitions.
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study generated a homology model of the NUDT9-H 
domain and docked ADPR into the anticipated AD-
PR-binding pocket (Perraud et al., 2005). The docked 
ADPR took a different conformation in that the horse-
shoe-shaped molecule points its ends in the opposite 
direction from that of our model. In the present study, 
we generated a structure model of the NUDT9-H do-
main guided by the crystal structure of NUDT9 and 
defined the ligand-binding pocket formed by the 
NUDT9-H domain using structural modeling, ligand 
docking simulations, and MD simulations. Our MD 
simulation results predicted that 11 residues in the 
binding pocket interact strongly with ADPR through 
VDW forces, electrostatic interactions, polar solvation 
interactions, and nonpolar solvation interactions. By 
combining MD simulations with site-directed muta-
genesis studies, we demonstrated that all of the identi-
fied residues in the NUDT9-H domain interact with 
ADPR, supporting our predicted binding pocket 
model for TRPM2.
The homology model of the NUDT9-H domain in 
our study is very similar to the model reported in a 
previous study (Perraud et al., 2005), which is not sur-
prising given the high sequence similarity between 
NUDT9-H and human NUDT9. However, our pre-
dicted ADPR binding pocket and the binding orienta-
tion of ADPR are clearly different from those in the 
earlier model. To test whether ADPR can bind in the 
previously proposed orientation, we also docked ADPR 
into the NUDT9-H domain in a similar orientation 
(Fig.  8  A). We found that this orientation yielded a 
much reduced docking IFD score (Table 4). To more 
easily compare this model with our predicted one, we 
merged them together (Fig. S3) and found ADPR in 
this orientation would interact with NUDT9-H at sev-
eral additional and potentially important residues, in-
cluding D1287, S1338, S1340, N1345, S1382, and 
I1440. Among these residues, D1287, S1340, and 
N1345 were previously proposed to interact with ADPR 
but not examined further using functional assays 
(Shen et al., 2003). Therefore, we mutated these resi-
dues to alanine individually and examined by patch-
clamp recording of ADPR-induced currents in cells 
expressing the mutant channels. Both the D1287A and 
S1340A mutant channels had normal activity induced 
by ADPR (Fig. 8, B–F), supporting the conclusion that 
Figure 7. Binding pocket of AdPR in the 
nudt9-H domain presented from different ori-
entations. A and B show the side (A) and top view 
(B) of the ADPR‑binding model in the NUDT9‑H 
domain. The positively and negatively charged res‑
idues are colored in blue and red, respectively. (C) 
The whole view of the binding pocket of ADPR in 
the NUDT9‑H domain. Critical residues for binding 
are labeled in green.
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these residues have no major role in ADPR binding. 
Both the model proposed by Perraud et al. (2005) and 
our model are based on the crystallographic informa-
tion of human NUDT9, which contained a ligand mol-
ecule, R5P (Shen et al., 2003). In the previous model, 
ADPR assumes a horseshoe-like conformation that 
bends over the superficial surface of the ADPR-bind-
ing pocket (Perraud et al., 2005). However, this does 
not match the position of R5P in the crystal structure 
of NUDT9. To illustrate the difference in these bind-
ing models, we highlight the critical residues (W110, 
N168, M216, R273, M280, and D305) identified in the 
Perraud model in red in our structure model (Fig. 9, A 
and B). In our model, ADPR locates in a deeper cleft, 
a position consistent with that of R5P in the cleft of the 
NUDT9 structure (Fig. 9, C and D). Of note, key resi-
dues that have been previously reported to interact 
with R5P in the crystal structure of the NUDT9 protein 
are also identified in our model for ligand binding, 
including Y1349 (D172), L1379 (R204), E1409 (E234), 
R1433 (R273), and H1488 (H324) (Fig. 9, E and F). 
Our mutagenesis and functional results demonstrate 
that these residues are indeed critical sites for ADPR 
binding to the NUDT9-H domain. These results lend 
further support for the accuracy of our ADPR 
binding model.
To further verify our model, we also examined how 
compatible our ADPR-binding pocket is with the re-
sults from previously published studies. First, a recent 
study reported that when the 2’-hydroxyl group of 
ADPR was replaced with a phosphate group, it could 
still function as a ligand of TRPM2 (Tóth et al., 2015). 
This can be explained by our model: there is an open 
space at the vicinity of the 2’-hydroxyl of ADPR that can 
conceivably accommodate both the extra mass and the 
more polar phosphate group (Fig.  7  A). Second, 
Figure 8. evaluation of a previous model for AdPR binding to the nudt9-H domain. (A) The previously proposed orientation of 
ADPR shown in the NUDT9‑H domain using our present model. In this orientation, ADPR is in close proximity to several residues for 
which mutations did not affect binding. Current traces of WT TRPM2 (B) and mutants at three positions (C–E) predicted to interact 
with ADPR in the orientation shown in A. (F) Summary of the currents from the mutants at the three positions when activated by 
ADPR 100 µM. Data are expressed as mean ± SEM from at least five independent repetitions.
Table 4. comparing of the IFd scoring of the model similar to the one previously proposed and our prediction
Models docking score Glide gscore Glide emodel Prime energy IFd score
kcal/mol kcal/mol kcal/mol kcal/mol kcal/mol
Our prediction −8.4 −8.4 −98.13 −3,710.1 −3,823.0
The model similar to the one previously 
proposed
−5.9 −5.9 −90.7 −3,644.7 −3,750.5
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Moreau et al. (2013) synthesized several ADPR ana-
logues and examined their effects on the function of 
TRPM2. They found that a compound, as modified 
with a phenyl group at C8 of the adenine and simulta-
neously modified with a 2’-deoxy motif at the adenos-
ine ribose (8-phenyl-2-deoxy-ADPR), became a highly 
potent and specific antagonist with high affinity for the 
NUDT9-H domain (half-maximal inhibitory concen-
tration of 3 µM). Consistently, our model has a cavity 
close to the purine ring of ADPR in the binding pocket 
that can accommodate a phenyl group (Fig. 7 A). Be-
cause only the C8-position-modified ADPR analogues 
exhibit highly antagonistic activities, the adenosine 
base of ADPR may very well be a critical factor in ADPR 
binding and gating of the TRPM2 channel. Finally, 
most of the residues identified in the present study 
have not been studied previously. The only exception is 
E1409, which was tested in two studies using an E-to-K 
mutation (Perraud et al., 2005; Tóth et al., 2014). The 
E1409K mutation was found to have little impact on 
ADPR binding to the NUDT9-H domain. Our simula-
tions predicted no electrostatic interaction between 
the terminal ribose of ADPR and the hydroxyl oxygen 
atom of E1409. This prediction was further validated 
by our results from the E1409Q and E1409A mutants. 
Although we did not test the E1409K mutant, the re-
ported results supported our model: by reversing the 
charge carried by the side chain, the E1409K mutation 
retained the polar solvation interaction but reversed 
the electrostatic interaction, further indicating that 
the electronic properties of E1409 do not affect ADPR 
binding to the NUDT9-H domain. All of these results 
further confirm the power and effectiveness of the 
methodological strategy of combining computation 
with experimental assays.
In summary, we revealed in this study the structural 
basis for ADPR binding to the NUDT9-H domain in the 
TRPM2 channel. Accumulating evidence has indicated 
TRPM2 is a potential therapeutic target for many dis-
eases, and our findings will not only significantly ad-
vance the understanding of the molecular mechanisms 
of TRPM2 channel activation by ADPR, but will also 
provide the structural basis for future drug design ef-
forts targeting the TRPM2 channel.
Figure 9. Molecular surface rep-
resentation for the structure of the 
nudt9 and nudt9-H domains. (A) 
The side view of molecular surface 
representation for the NUDT9 struc‑
ture. The previously proposed critical 
residues (W110, N168, M216, R273, 
M280, and D305) are highlighted in 
red. (B) The side view of molecular sur‑
face representation for the structure of 
NUDT9‑H domain. The same critical 
residues shown in A are labeled in red. 
(C) Molecular surface representation for 
the structure of NUDT9 domain bind‑
ing with R5P in the previously reported 
model. (D) Molecular surface represen‑
tation for the structure of NUDT9‑H 
domain binding with ADPR in our struc‑
ture model. (E) D172, R204, E234, R273, 
and H324 residues labeled in red inter‑
act with R5P in the crystal structure of 
the NUDT9 protein. (F) Y1349, L1379, 
E1409, R1433, and H1488 residues that 
were reported to interact with R5P are 
labeled in in our NUDT9‑H structure to 
interact with ADPR.
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